Literature DB >> 15025322

Co-infection with hepatitis C virus and human immunodeficiency virus among patients with sexually transmitted diseases in Pondicherry, South India.

S Bhattacharya1, S Badrinath, A Hamide, S Sujatha.   

Abstract

Hepatitis C virus (HCV), which is usually transmitted by blood and blood products is emerging as an important agent in the list of sexually transmitted diseases (STDs). The present study was undertaken to document the burden of HCV infection in individuals with STDs in this tertiary care hospital in South India. One hundred serum samples collected from individuals with STDs were tested for antibodies to HCV by a third generation ELISA. All the samples were also screened for HIV infection. Six out of 100 individuals were found to possess antibodies against HCV (95% confidence interval [CI=1.3-10.7%). Fourteen out of 100 samples were positive for HIV (95% CI=7-20.9%). The seroprevalence of HCV in HIV positive individuals was 21.4% (3/14) whereas the corresponding figure for HIV negative individuals was only 3.5% (3/86). The difference was found to be statistically significant (p<0.01).

Entities:  

Mesh:

Year:  2003        PMID: 15025322

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  10 in total

Review 1.  Hepatitis C in India.

Authors:  Ashis Mukhopadhyaya
Journal:  J Biosci       Date:  2008-11       Impact factor: 1.826

2.  Seroprevalence of HCV and its co-infection with HBV and HIV among liver disease patients of South Tamil Nadu.

Authors:  Ganesh Kumar Anbazhagan; Sridharan Krishnamoorthy; Thirunalasundari Thiyagarajan
Journal:  World J Hepatol       Date:  2010-01-27

3.  Hepatitis B and C virus co-infections in human immunodeficiency virus positive North Indian patients.

Authors:  Swati Gupta; Sarman Singh
Journal:  World J Gastroenterol       Date:  2006-11-14       Impact factor: 5.742

4.  Coinfection of hepatitis B and hepatitis C virus in HIV-infected patients in south India.

Authors:  Shanmugam Saravanan; Vijayakumar Velu; Nagalingeswaran Kumarasamy; Subhadra Nandakumar; Kailapuri Gangatharan Murugavel; Pachamuthu Balakrishnan; Solomon Suniti; Sadras Panchatcharam Thyagarajan
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

5.  Prevalence and risk factors of asymptomatic hepatitis C virus infection in Egyptian children.

Authors:  M S El-Raziky; M El-Hawary; G Esmat; A M Abouzied; N El-Koofy; N Mohsen; S Mansour; A Shaheen; M Abdel Hamid; H El-Karaksy
Journal:  World J Gastroenterol       Date:  2007-03-28       Impact factor: 5.742

6.  The current seroprevalence of hepatitis C virus in a tertiary care centre in vellore, Tamil Nadu.

Authors:  V Gowri; C Chandraleka; R Vanaja
Journal:  Indian J Community Med       Date:  2012-04

7.  Recent pattern of Co-infection amongst HIV seropositive individuals in tertiary care hospital, Kolkata.

Authors:  Kallol Saha; Rushna Firdaus; Poonam Santra; Jyotirmoy Pal; Arnab Roy; Mihir K Bhattacharya; Sekhar Chakrabarti; Provash C Sadhukhan
Journal:  Virol J       Date:  2011-03-14       Impact factor: 4.099

8.  Economic Evaluation of Implementing a Rapid Point-of-Care Screening Test for the Identification of Hepatitis C Virus under National Viral Hepatitis Control Programme in Tamil Nadu, South India.

Authors:  Muniyandi Malaisamy; Karikalan Nagarajan; Tyagi Kirti; Singh Malkeet; Prakash Venkatesan; S Senthilkumar; Karthikeyan Sananthya; Krishnan Rajendran; Rajsekar Kavitha; Shanmugam Vivekanandan; T S Selvavinayagam
Journal:  J Glob Infect Dis       Date:  2021-08-31

9.  Time trends of seroepidemiology of hepatitis C virus and hepatitis B virus coinfection in human immunodeficiency virus-infected patients in a Super Specialty Hospital in New Delhi, India: 2012-2014.

Authors:  Abha Sharma; Jasmin Halim; Tavleen Jaggi; Bibhabati Mishra; Archana Thakur; Vinita Dogra; Poonam Sood Loomba
Journal:  Indian J Sex Transm Dis AIDS       Date:  2016 Jan-Jun

Review 10.  Hepatitis C virus infection in children in the era of direct-acting antiviral.

Authors:  Malgorzata Pawlowska; Malgorzata Sobolewska-Pilarczyk; Krzysztof Domagalski
Journal:  World J Gastroenterol       Date:  2018-06-28       Impact factor: 5.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.